Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered non-small cell lung cancer and thyroid cancer patients who may be suitable for LOXO-292, Lilly’s RET inhibitor CARLSBAD, Calif. — Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S […]
SAN DIEGO–Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company continues reinforcing the foundation for long-term growth. Jonathan will join Illumina on January 3, 2017. Jonathan Seaton “Jonathan is a strong leader with an established track […]
SANTA CLARA, Calif., and NIEL, Belgium Agilent Technologies Inc. (NYSE: A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products. Multiplicom, headquartered in Niel, Belgium, develops, manufactures and commercializes molecular-diagnostic solutions, provided as kits, which […]
–Identifies Tumor-Specific, Clinically Actionable Genetic Alterations to Inform Treatment Decisions with Unparalleled Accuracy– BALTIMORE — Personal Genome Diagnostics Inc. (PGDx), a leading provider of advanced cancer genome testing products and services, today announced the launch of its CancerSELECT™ 125 test for pan-cancer tumor profiling. CancerSELECT 125 identifies clinically actionable and functionally important sequence mutations and structural […]
MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that F. Hoffman-La Roche Ltd(Roche) has elected to terminate for convenience the development, commercialization and license agreement with Pacific Biosciences for the development and supply of diagnostic products based on the company’s Single Molecule, Real-Time (SMRT®) technology. The agreement, which was entered into by […]
PLEASANTON, Calif. — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has officially notified Pacific Bioscience (PacBio) of its intention to terminate its agreement and efforts to develop a sequencing instrument for use in the clinical research and clinical market using their Single Molecule, Real-Time (SMRT®) technology. With this termination, Roche no longer retains rights […]
Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its range of Cytocell Aquarius® fluorescence in situhybridisation (FISH) probes for pathology. OGT has introduced three new probes: FUS Breakapart andFOXO1 Breakapart, both carrying the CE-IVD label – and TFE3 Breakapart, for research use only. This expansion reinforces OGT’s commitment to providing the most […]
QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as Non Executive Director. Recognised with an OBE in 2014 for her services to Innovation in Healthcare, Elaine will bring 25 years’ of experience in healthcare and biotechnology to the board alongside first-hand experience of the challenges […]
MINNEAPOLIS and SAN DIEGO — Bio-Techne Corporation (NASDAQ: TECH) today closed on a strategic equity investment in Astute Medical, Inc. (San Diego, CA), a diagnostic company devoted to improving patient healthcare outcomes through the identification and validation of novel biomarkers. Certain existing Astute Medical investors also participated in the financing, which totaled $43 million. This transaction has […]
GenDx and Illumina Netherlands BV have recently signed a reseller agreement. According to which GenDx is appointed as a non-exclusive reseller of Illumina products, instruments, such as MiSeq® and MiniSeq® and reagents, as well as maintenance contracts for the field of HLA sequencing in a restricted number of countries, including Benelux, Italy, United Kingdom, Germany […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
